Objectives: To detect the presence of lnu genes in staphylococcal strains with the unusual phenotype lincosamide resistance/macrolide susceptibility (L R /M S ), and to determine their locations and genetic environments.
Introduction
The lincosamides constitute a group of antibiotics employed to treat staphylococcal and streptococcal infections in human and veterinary medicine. This group is classified together with macrolides and streptogramins (group MLS), owing to the fact that they share their binding site. The main mechanism of resistance to these MLS antimicrobials in staphylococci is encoded by erm genes. 1 In contrast, lnu genes confer resistance only to lincosamides. Five lnu genes have been described so far: lnu(A), lnu(B), lnu(C), lnu(D) and lnu(F). A priori, these genes only confer resistance to lincomycin and pirlimycin, although resistance to clindamycin has been also suggested. 2 Recently, the detection of the unusual resistance phenotype lincosamide resistance/macrolide susceptibility (L R /M S ) has increased among staphylococcal strains of animal origin. 3, 4 The aims of this study were to determine the presence of lnu genes, their locations and genetic environments in methicillinresistant Staphylococcus aureus (MRSA) and in other staphylococcal strains that showed the unusual resistance phenotype L 
Materials and methods

Bacterial strains
Six Staphylococcus spp. strains, which showed the unusual resistance phenotype L R /M S , were included in this study: five S. aureus [three MRSA and two methicillin-susceptible S. aureus (MSSA)] and one methicillin-resistant Staphylococcus sciuri (MRSC).
Antimicrobial susceptibility testing
Susceptibility testing was performed by the disc diffusion method following CLSI guidelines. 5 The tested antibiotics were as follows: penicillin, oxacillin, cefoxitin, erythromycin, clindamycin, gentamicin, streptomycin, kanamycin, tobramycin, tetracycline, ciprofloxacin, chloramphenicol, trimethoprim/sulfamethoxazole, vancomycin, teicoplanin, mupirocin and fusidic acid. In addition, the MICs of clindamycin, lincomycin, erythromycin, linezolid, tiamulin, virginiamycin and chloramphenicol were determined by the agar dilution method. 5, 6 CLSI breakpoints were used for all antibiotics, 5 except for lincomycin, for which Société Française de Microbiologie breakpoints were considered, 6 and for tiamulin and virginiamycin due to the lack of officially approved breakpoints.
Resistance genotype
The presence of the lnu(A), lnu(B), lnu(C) and lnu(D) genes was analysed by PCR and sequencing (Table S1 , available as Supplementary data at JAC Online). The presence of the vga(A), vga(B), vga(C), vga(E), lsa(B), cfr, tet(K), tet(L), tet(M), tet(O), aacA-aphD, aadD, aphA3, dfrS1, dfrD, dfrG and dfrK resistance genes was also studied by PCR, as previously described.
4,7
Molecular typing
Two of the strains (C1841 and C2944) were typed in previous studies. 7, 8 The remaining S. aureus strains were typed [spa typing, agr typing and multilocus sequence typing (MLST)] as previously described. 7 SCCmec typing was performed for the methicillin-resistant strains. 7 Moreover, due to the similar genetic background of the two MSSA strains, PFGE was performed as recommended. 9 
Location of the lnu genes
A plasmid or chromosomal gene location was determined by Southern blot analysis. Two methods were used to detect a possible plasmid location: the S1-PFGE assay and plasmid DNA extraction. 4, 10 Moreover, I-CeuI-PFGE was performed to detect a possible chromosomal location. Hybridizations were carried out with lnu(A) and lnu(B) probes, and a 16S rDNA probe (in the case of I-CeuI), according to the manufacturer's recommendations (Roche).
Transformation experiments and genetic environment of the lnu(A) gene
Transformation experiments were performed by electrotransformation into the recipient strain S. aureus RN4220. 10 Putative transformants were selected on brain heart infusion plates containing lincomycin (8 mg/L). The genetic environments of the lnu(A) genes were studied by inverse PCR and sequencing. The primers used for amplification were lnu(A)inv-F and lnu(A)inv-R (Table S1 , available as Supplementary data at JAC Online). Plasmids containing the lnu(A) gene were completely sequenced by primer walking using the PCR primers as the initial primers.
Genetic environment of the lnu(B) gene
To determine the genetic environment of the lnu(B) gene, primers were designed based on the previously reported pEF418 structure (GenBank accession number AF408195.1) (Table S1 , available as Supplementary data at JAC Online). In addition, whole-cell DNA of the MRSA C2944 strain was digested with PvuII (New England Biolabs) and subjected to ligation with T4 ligase (Fermentas). An inverse PCR was performed using the 1_inv-F and 2_inv-R primers (Table S1 , available as Supplementary data at JAC Online and see Figure 1a ), and the amplicon was sequenced. Due to the identification of IS257 upstream of the detected genetic structure, primers were designed to determine whether the same insertion sequence was also downstream of the lnu(B) gene (Table S1 , available as Supplementary data at JAC Online). Primers based on the structure detected in the C2944 strain were designed and tested in C2828 and C2829. Putative circular forms were also investigated by inverse PCR and sequencing using the primers 2_inv-R and pEF418-4-F (Table S1 , available as Supplementary data at JAC Online).
Results and discussion
Two MRSA strains (ST398 and ST125) of animal and human origin, respectively, and one MRSC of animal origin carried the lnu(A) resistance gene. Moreover, three strains (one MRSA ST398 and two MSSA ST9) of human origin revealed the presence of the lnu(B) gene (Table 1) . Both MSSA strains showed closely related patterns by PFGE. Previous reports indicated that the MRSA lineage ST398 is a livestock-associated (LA) MRSA, frequently encountered in farm animals, although it is appearing in the human population. 11 Another identified LA staphylococcal lineage is ST9, which has been reported in animal MRSA and MSSA isolates. 12, 13 It seems that there is a relationship between the lnu(A) and lnu(B) resistance genes and animal clonal lineages of S. aureus. This fact has been suggested before, since other resistance genes responsible for the unusual resistance phenotype L R /M S have been detected in MRSA ST398 strains. 3, 4, 14 The use of lincosamides in veterinary medicine could explain the presence of these resistance genes in strains of animal origin. 4 In this study, the lnu(A) gene was also identified in an MRSA ST125 strain of human origin. The ST125 lineage is the most commonly found hospital-acquired MRSA clone in Spain and the detection of this gene in a human strain is remarkable. 1, 15 The MIC values obtained for the lnu(A)-positive strains are in concordance with the results obtained by others. 10 However, MRSC strain C2376 showed a higher tiamulin MIC value than the remaining lnu(A)-positive strains (Table S2 , available as Supplementary data at JAC Online). None of the tested genes involved in tiamulin resistance was detected in strain C2376. Only the MIC value of lincomycin was increased for transformant strains with respect to the recipient strain (Table S2) .
The three lnu(B)-positive strains presented higher MIC values of lincomycin, clindamycin and tiamulin than the lnu(A)-positive strains (Table S2 ). The Lnu(A) protein modifies a hydroxyl group of clindamycin and lincomycin at positions 3 and 4, respectively. Nevertheless, the Lnu(B) protein modifies a hydroxyl group at position 3 in both antimicrobials. 2 This fact and the presence of a gene encoding an ABC transporter upstream of the lnu(B) gene in our strains (Figure 1a ) could explain the detected phenotype. Interestingly, this ABC transporter showed a similarity of 76.5% with respect to the staphylococcal Lsa(B) protein. 16 
lnu(A) and lnu(B) resistance genes in staphylococci
Hybridization experiments revealed the location of the lnu(A) gene in small plasmids (from 2.3 to 2.7 kb) in our strains. Sequencing of the inverse PCR products showed that the MRSA ST398 strain and the MRSC strain harboured a lnu(A) plasmid identical to pLNU1 (with a GC content of 29% and a size of 2361 bp) of Staphylococcus chromogenes (GenBank AM184099.1).
The MRSA ST125 strain presented a novel lnu(A)-plasmid (named pUR5425) of 2690 bp, 31% GC content and with a ) and the structure of the already described Enterococcus plasmid pEF418. The PvuII cleavage site is shown. The positions of primers used to amplify the genetic environment of the lnu(B) gene are indicated by arrows and numbers as follows: 1, C2944-tnp-F; 2, 2_inv-R; 3, 1_inv-F; 4, pEF418-2-F; 5, pEF418-3-R; 6, pEF418-1-F; 7, pEF418-2-R; 8, pEF418-1-R; 9, pEF418-4-F; and 10, IS257-R. (b) Structure of the novel plasmid containing the lnu(A) gene (strain C5425) and the already described plasmids pLNU1 and pLNU4. Some of the differences between pLNU4 and the novel plasmid pUR5425 are shown in boxes. Amino acid changes in the lincosamide nucleotidyltransferase protein between pLNU1 and pUR5425 (with a lincosamide nucleotidyltransferase similar to pLNU4) are also shown in a box.
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high similarity (92.8%) to the previously described plasmid pLNU4 (GenBank AM184102.1). This novel plasmid was registered in GenBank (JQ861958.1). The most notable differences between pUR5425 and pLNU4 were the presence of amino acid changes in the Rep protein, and several variations in the region between the rep gene and the single-strand origin (Figure 1b) . The Lnu(A) protein encoded by the plasmids detected in this study presented some amino acid exchanges. Variability of the Lnu(A) amino acid sequence has already been described. 10 No transformants were obtained from lnu(B)-positive strains. Few data exist on the location of the lnu(B) gene and its genetic environment. A plasmid location ( 240 kb) was suggested in the first description of this gene. 17 Additionally, in that study, it was observed that the lnu(B) gene could be integrated into the chromosome of the obtained transconjugant. These results are in agreement with our observation since this gene was embedded in the chromosome of our two MSSA strains and in a large-sized plasmid (250 kb) in our MRSA strain C2944. Up to now, only a partial sequence of one lnu(B)-carrying plasmid (pEF418) of Enterococcus faecalis is available in GenBank. In our strains, the region that immediately preceded the lnu(B) gene was homologous to pEF418 and this region included other resistance genes, such as aadE or spc (Figure 1a) . Moreover, two insertion sequences (both IS257) flanked the structure detected and a circular structure was identified ( Figure 1a ). This fact indicates that the lateral transfer could occur possibly mediated by the presence of the two insertion sequences that would enable the mobilization of the lnu(B) gene. Further studies are required to confirm this hypothesis. The genetic environment of the lnu(B) gene detected in strain C2944 was also identified in the two other lnu(B)-positive strains studied and was registered in GenBank (JQ861959.1).
The transference of resistance genes among bacterial genera and species has been corroborated in this study. Firstly, two of the lnu(A)-positive strains (one MRSA and one MRSC) contained this gene in the plasmid pLNU1, which was previously described in S. chromogenes. 10 The transference of this gene among different staphylococcal species is expected since the lnu(A) gene has been detected in S. aureus, Staphylococcus pseudintermedius, S. chromogenes, Staphylococcus simulans, Staphylococcus haemolyticus and Staphylococcus epidermidis. 8, 10, 18 Moreover, the lnu(B) gene was identified in three S. aureus strains in this study. This gene has been detected in Enterococcus spp., Streptococcus spp. and Clostridium spp. 17, 19, 20 Regarding staphylococci, there is no information in the National Center for Biotechnology Information (NCBI) database about strains harbouring the lnu(B) gene. However, according to the web site http://faculty.washington. edu/marilynr/ermweb4.pdf, this gene has been already detected in the Staphylococcus genus. Therefore, our study describes the first report of this gene in MRSA of the lineage ST398.
In conclusion, the unusual resistance phenotype L R /M S seems to be related to animal clonal lineages of S. aureus. We describe a novel lnu(A)-carrying plasmid and, to the best of our knowledge, this is the first description of the lnu(B) gene in MRSA ST398.
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